Other Search Results
0001104659 21 078562 txt

UNITED STATES · SECURITIES AND EXCHANGE COMMISSION · WASHINGTON, D.C. 20549 · FORM 8-K · CURRENT REPORT · PURSUANT TO SECTION 13 OR 15(D) OF THE · SECURITIES EXCHANGE ACT OF 1934 · Date of Report (date of earliest event reported): June 9, 2021 · (Exact name of registrant as specified in its charter)

0001104659-22-034250.txt

FUELCELL ENERGY, INC. Michael S. Bishop · Executive Vice President, Chief Financial Officer and Treasurer

0001104659-16-093792.txt

Item 7.01 Regulation FD Disclosure · AAR CORP.’s Vice President, Chief Financial Officer and Treasurer, Michael J. Sharp, presented at the Cowen and Company 37th Annual Aerospace/Defense & Transportation Conference on Thursday, February 4, 2016 in New York City. Attached as Exhibit 99.1 are the slides used by Mr. Sharp in his presentation. The information in this Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of t...

0001104659-12-002881.txt

Item 2.02. Results of Operations and Financial Condition. The registrant’s press release dated January 19, 2012, regarding its financial results for the periods ended December 31, 2011, including consolidated financial statements for the periods ended December 31, 2011, is Attachment I of this Form 8-K. Attachment II are the slides for IBM’s Chief Financial Officer Mark Loughridge’s fourth quarter earnings presentation on January 19, 2012, as well as certain reconciliation and other inform...

https://www.sec.gov/Archives/edgar/data/717720/000110465911039579/0001104659-11-039579.txt

30 ROCKEFELLER PLAZA, ABU DHABI ; NEW YORK, NEW YORK, AUSTIN ; 10112-4498, BEIJING ; TEL +1 212.408.2500, DUBAI ; FAX +1 212.408.2501, HONG KONG ; www.bakerbotts.com, HOUSTON ; , WASHINGTON

0001140361-21-009531.txt

nc10021295x2_defa14a.htm DEFA14A ; UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ; SCHEDULE 14A (Rule 14a-101) ; Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

https://www.sec.gov/Archives/edgar/data/1802665/000155837024013802/0001558370-24-013802.txt

Item 2.02. Results of Operations and Financial Condition. On October 29, 2024, Harmony Biosciences Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2024. A copy of this press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Item 7.01. Regulation FD Disclosure. On October 29, 2024, the Company posted an investor presentation to its website at ttps://ir.harmo...

https://www.sec.gov/Archives/edgar/data/17313/000114036115035162/0001140361-15-035162.txt

/s/ Joseph B. Armes, /s/ Joseph B. Armes ; Name:, Joseph B. Armes ; Title:, Chairman of the Board,

0001140361-24-018157.txt

UNITED STATES · SECURITIES AND EXCHANGE COMMISSION · Washington, D.C. 20549 · SCHEDULE 14A · Proxy Statement Pursuant to Section 14(a) of · the Securities Exchange Act of 1934 (Amendment No. ) · Filed by the Registrant ☒ · Filed by a Party other than the Registrant ☐

0001104659-22-067883.txt

EX-10.1 2 tm2217179d1_ex10-1.htm EXHIBIT 10.1 ; Exhibit 10.1 · Execution Version · SIXTH AMENDED AND RESTATED CREDIT AGREEMENT · dated as of May 27, 2022 · among · UNITED STATES STEEL CORPORATION · THE LENDERS PARTY HERETO · THE LC ISSUING BANKS PARTY HERETO and · JPMORGAN CHASE BANK, N.A., as Administrative Agent and Collateral Agent · JPMORGAN CHASE BANK, N.A., BANK OF AMERICA, N.A., WELLS FARGO BANK, NATIONAL ASSOCIATION, and · BARCLAYS BANK PLC, as Joint Lead Arrangers an...

Copyright © www.babybloodtype.com. All rights reserved.
policy sang_list